Regeneron Just Bought Your DNA From 23andMe
Digest more
Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to close in Q3 2025
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.
1d
Stocktwits on MSNRegeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D EffortsDrugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology company 23andMe Holding Co. for $256 million. Regeneron intends to acquire 23andMe’s Personal Genome Service (PGS),